鴉片類藥物

哌噴他多

購買去甲利地因

PiPTapentadol – Wholesale 哌噴他多

哌噴他多 is a structural analogue of tapentadol featuring a piperidine-type substitution on the phenylpropylamine scaffold. 哌噴他多 is an opioid analgesic, a Tapentadol derivative with similar effects. This drug acts as an 促效劑 的 μ opioid 受體  a norepinephrine reuptake inhibitor (NRI). This drug is a designer tool for detecting analgesic properties in laboratory conditions.

價格:

哌噴他多 5 g 100 $ 加入購物車

哌噴他多 10 g 160 $ 加入購物車 

哌噴他多 50 g 380 $ 加入購物車 免費運送!

哌噴他多 100 g 600 $ 加入購物車 免費運送!

哌噴他多 500 g 2000 $ 加入購物車 免費運送

哌噴他多 1 kg 3500 $ 加入購物車 免費運送

 PiPTapentadol – Structural and Pharmacological Overview

Chemical Classification

哌噴他多 is a synthetic opioid analogue structurally derived from tapentadol, itself a centrally acting analgesic combining μ-opioid receptor agonism with norepinephrine reuptake inhibition (NRI).
In PiPTapentadol, the primary amine group of tapentadol is substituted with a piperidine or piperazine-type moiety, altering its receptor affinity and pharmacokinetic properties.

This modification places PiPTapentadol within the broader arylmethylamine / phenethylamine opioid family, alongside other designer analogues investigated in forensic toxicology and receptor mapping research.

Chemical Features

  • Base structure: Derived from (±)-3-(3-hydroxyphenyl)-N,N-dimethylmethylbutanamine (tapentadol scaffold)
  • Typical substitution: Replacement of the primary amine with piperidine or isopropylpiperidine (PiP) group
  • Functional groups: Phenolic hydroxyl, tertiary amine, secondary alcohol
  • Predicted molecular weight: ~275–310 g/mol (depending on salt form)
  • Likely salt forms: Hydrochloride or fumarate

Pharmacology (Predicted from Structural Analogy)

  1. μ-Opioid Receptor Agonism (MOR):
    The phenolic hydroxyl and basic amine group maintain MOR affinity similar to tapentadol, conferring analgesic and sedative properties in receptor assays.
  2. Norepinephrine Reuptake Inhibition (NRI):
    The extended amine side chain may preserve NRI activity, suggesting a dual mechanism combining opioid and noradrenergic modulation.
  3. Reduced Serotonin Reuptake Affinity:
    Compared to tramadol analogues, PiPTapentadol likely exhibits minimal serotonergic effect.
  4. Expected effects (research observation):
    • Central analgesia (MOR-mediated)
    • Sedation, miosis, respiratory depression (dose-dependent)
    • Elevated norepinephrine tone (mild stimulant-like property at low doses)

Toxicology and Safety Considerations

  • No human pharmacokinetic data are available.
  • As with all novel opioid analogues, PiPTapentadol presents high risk for respiratory depression, CNS depression, and dependence.
  • Cross-tolerance with other opioids is likely but unpredictable.
  • In forensic casework, analogues of tapentadol have been implicated in fatal overdoses when misused.
  • Analytical detection may require LC-MS/MS with specific precursor ion transitions unique to the PiP-substituted moiety.

Forensic and Analytical Use

PiPTapentadol may appear in the context of:

  • Designer opioid screening panels
  • Toxicological reference standard development
  • Structure–activity relationship (SAR) modeling for synthetic analgesics

Legal and Ethical Context

  • Tapentadol is a controlled prescription opioid in most jurisdictions.
  • Its analogues (including PiPTapentadol) are unapproved for medical use and may fall under analogue or NPS control laws.
  • Any handling should comply with local controlled substance regulations and be limited to licensed analytical or academic laboratories.

 Summary

哌噴他多 is a tapentadol-derived experimental opioid analogue investigated for its unique receptor binding and pharmacological profile. It combines μ-opioid agonism with potential norepinephrine reuptake inhibition, but lacks formal toxicological, safety, or clinical data. Research use is strictly limited to controlled laboratory environments with full compliance to applicable regulations.

哌噴他多
哌噴他多

 

 

 

 

同義詞
  • 哌噴他多
  • PiPTapentadol HCL
國際純化學與應用化學聯合會    3-(2-methyl-1-(piperidin-1-yl)pentan-3-yl)phenol
公式    C17H27NO
分子量    261.41 g/mol
CAS
外觀    A neat solid
純度    ≥ 98 %

 

-從以下產品中挑選您最喜愛的: Chems Axis , ,並保證以最優惠的價格提供卓越的品質。.

-信封會在付款後 24 小時內寄出。.
送達時間為 3 至 4 個工作天。.
100% 配送服務遍及全歐洲。.

-您必須了解您訂購的產品在您所在國家/地區的法律地位。.
-在我們的網站上訂購滿 250 美元,即可享受免運費優惠。. 透過 $ 250 下單時,系統會自動扣除運費。. 

最佳購買地點 哌噴他多 線上購買 | 哪裡買 哌噴他多

哌噴他多 is a synthetic opioid analogue structurally derived from tapentadol, itself a centrally acting analgesic combining μ-opioid receptor agonism with norepinephrine reuptake inhibition (NRI). In PiPTapentadol, the primary amine group of tapentadol is substituted with a piperidine or piperazine-type moiety, altering its receptor affinity and pharmacokinetic properties. We are happy to answer your questions or provide more information.

管理員

發表評論

發佈留言必須填寫的電子郵件地址不會公開。 必填欄位標示為 *